A trial has begun in the US to see whether you have Alzheimer’s disease can be prevented.
Healthy individuals aged between 65 and 85 are being sought to take part in the research, whose brains may suggest that they are susceptible to some form of cognitive impairment in the future.
The test objective is to control beta amyloid levels in a period of three years. The more of this protein that is present in the brain, the greater the risk of developing degenerative condition. However, it does not always mean some form of dementia will develop.
An experimental medicine – solanezumab – is being used with the hope that detect beta amyloid before it is based on the brain plaques and has a detrimental effect on cognitive ability.
Dr. Reisa Sperling, of Boston’s Brigham and Women’s Hospital and Harvard Medical School, who led the trial, said. “Amyloid know it is a big risk factor, but someone can have a head full of amyloid and not mentally decreases We need to better understand why some brains are resilient and some are not. “
Before brain scans are performed, participants will under certain evidence to ensure that they do not fight today with any memory loss.
“We have to get at the stage where we can save their brains,” said Dr. Sperling.
Peter Bristol, who lives in Rhode Island, was the first person to be treated. He decided to take part in this study because their mother had the condition, while his brother currently has.
He said he felt it was important for him to be proactive and that his wife and he is in this process with its “open eyes”.
Similar tests will be conducted in Canada and Australia, in what is thought to be one of the most ambitious attempts to address degenerative disease. This study will cost $ 140 million (£ 83 million) and is being funded by the National Institutes of Health, Lilly and others.
heads: Find out dementia care and support Barchester care homes.
This article was originally published on barchester, Read the original article here
Posted in: Alzheimer's & Dementia